XBIT Insider Trading Activity and SEC Form 4 Filings
XBIT insider trading summary
Over the past 12 months, insiders at XBiotech Inc. (XBIT) reported 1 open-market purchase worth $711K by 1 insider and no sales on SEC Form 4. Net insider buying was $711K.
Latest XBIT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 26, 2026 | John Simard | Insider | Buy | $711K (368,524 @ $1.93) |
| Oct 18, 2021 | John Simard | Chief Executive Officer | Sell | $431K (33,000 @ $13.07) |
| Oct 15, 2021 | John Simard | Chief Executive Officer | Sell | $226K (17,000 @ $13.32) |
| Oct 14, 2021 | John Simard | Chief Executive Officer | Sell | $273K (21,125 @ $12.90) |
| Oct 13, 2021 | John Simard | Chief Executive Officer | Sell | $140K (10,875 @ $12.83) |
| Oct 12, 2021 | John Simard | Chief Executive Officer | Sell | $230K (18,000 @ $12.77) |
| Oct 7, 2021 | John Simard | Chief Executive Officer | Sell | $489K (39,286 @ $12.45) |
| Oct 6, 2021 | John Simard | Chief Executive Officer | Sell | $134K (10,714 @ $12.53) |
| Oct 5, 2021 | John Simard | Chief Executive Officer | Sell | $180K (14,218 @ $12.66) |
| Oct 4, 2021 | John Simard | Chief Executive Officer | Sell | $310K (23,681 @ $13.08) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.